you are viewing a single comment's thread.
Too loose money is not funny.Note: CLDX is years away from any kind of approval of CDX-110 and it is not clear if they are able to approve it, with sight on Avastin treatment of GBM.Meanwhile the company is burning millions of US$ cash each months ans quarter.Management is overpaid - earning more than the president of the United States.Try to do a due dilligence.M.
Avastin safety profile not good. I know somebody who had multiple strokes after.
hey onequestion doesn't cdx-110 have Fast Track Status with the FDA????